RedHill Biopharma Ltd. (RDHL) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 0.93 and resistance around 1.23. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 0.76, so a violation there would materially change the current setup narrative.

📊 Technical Summary

The latest close for RedHill Biopharma Ltd. (RDHL) came in at 1.09 (+4.81%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +34.07%; price is trading in the lower part of its roughly 52-week range (0.75–2.52); and ATR14 volatility is elevated at roughly 5.74% of price. RSI(14) stands near 75.3, suggesting strong bullish momentum with conditions becoming somewhat extended. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram is positive and expanding, pointing to improving upside momentum. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging Double bottom. Near-term structure is defined by support at 0.93 and resistance at 1.23. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more